Results 121 to 130 of about 6,539 (200)

Characteristics of Patients with Severe Uncontrolled Asthma in Saudi Arabia: A Cross-Sectional Study. [PDF]

J Asthma Allergy
Al-Lehebi RO, Saleh RA, Alasiri AM, Alghamdi BJ, Almudaiheem HY, Al-Jedai AH, Almutairi EA, Aldakhil H, Alokili KA, Zuriqan F, Bulkhi AA.   +10 more
europepmc   +1 more source

Effectiveness of Benralizumab in Reducing Asthma and COPD Exacerbations in Patients with Severe Asthma and Concomitant COPD: Real-World Evidence from the ZEPHYR-5 Study. [PDF]

Int J Chron Obstruct Pulmon Dis
Adrish M, DeMartino JK, Carstens D, Jackson M, Wilson K, Schinkel J, Tkacz J.   +6 more
europepmc   +1 more source

Clinical remission in patients with severe eosinophilic asthma treated with benralizumab over 24 months: Post hoc analysis of the ANANKE study. [PDF]

World Allergy Organ J
Canonica GW, Senna G, Brussino L, Aliani M, Altieri E, Bracciale P, Caiaffa MF, Cameli P, Caminati M, Caruso C, Centanni S, De Michele F, Del Giacco S, Di Marco F, Malerba L, Menzella F, Rogliani P, Romagnoli M, Schino P, Schroeder JW, Vultaggio A, D'Amato M, Pelaia G.   +22 more
europepmc   +1 more source

Real-World Effectiveness Following Benralizumab Use in Patients with Severe Eosinophilic Asthma in Romania: A Retrospective Cohort Study (BREEZE). [PDF]

J Clin Med
Toma CL, Teodorescu G, Mihălţan FD, Frent S, Ali S, Trenchea M, Constantin AA.   +6 more
europepmc   +1 more source

Real-World Safety and Effectiveness of Benralizumab in Japanese Patients with Severe Asthma: A Multicenter Prospective Observational Study

Journal of Asthma and Allergy
Masao Yamaguchi,1 Yoshihiro Nishimura,2 Yuko Takumi,3 Nobuya Hayashi,4 Kei Sakamoto,3 Yuji Tohda5 1Division of Respiratory Medicine, Third Department of Medicine, Teikyo University Chiba Medical Center, Ichihara, Chiba, Japan; 2Kita-Harima Medical Center,
Yamaguchi M, Nishimura Y, Takumi Y, Hayashi N, Sakamoto K, Tohda Y   +5 more
doaj  

Functional respiratory imaging reveals early structural and functional airway responses to benralizumab in severe eosinophilic asthma. [PDF]

BMJ Open Respir Res
Conemans L, Deng Q, Simons SO, Franssen FME, Spruit MA, Hajian B.   +5 more
europepmc   +1 more source

Biologics in Chronic Obstructive Pulmonary Disease: Current Status and Future Prospects. [PDF]

Tuberc Respir Dis (Seoul)
Choi JY.
europepmc   +1 more source

Benralizumab: Bringing winds of change to eosinophil-associated diseases. [PDF]

World Allergy Organ J
Korn S, Bleecker ER, Bourdin A, McCrae C, Jison ML, Menzies-Gow A.   +5 more
europepmc   +1 more source

From Anti-Neutrophil Cytoplasmic Antibody-Negative to Positive: Eosinophilic Granulomatosis with Polyangiitis Under Benralizumab After Steroid Cessation. [PDF]

J Clin Pract Res
Işık Ş, Yılmaz İ, Türk M, Açar E, Pektaş Alpsoy H.   +4 more
europepmc   +1 more source

Comparative effectiveness of biologics in lung function improvement among patients with severe asthma: a real-world study. [PDF]

Respir Res
Bourdin A, Canonica GW, Virchow JC, Borsos K, Stanford RH, Ledanois O, Kwah J, Ge W, Huynh L, Duh MS, Boca AE, Cheng WH, Gandhi A.   +12 more
europepmc   +1 more source